MedPath

Evaluation of the use of a nasal spray containing a small amount of seawater, after nasal surgery and its impact on improving the quality of life of patients

Phase 4
Recruiting
Conditions
asal obstruction
J32.9
J32.8
C08.460.525
Registration Number
RBR-5bxqm5
Lead Sponsor
Hospital IPO - Hospital Paranaense de Otorrinolaringologia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Both sexes; between 18-65 years; indication for surgery septoplasty and inferior bilateral turbinectomy with dislocation of the turbinate; agreement to abide by the procedures and requirements of the test and attend to the Office (s) day (s) and time (s) given (s) for the evaluations

Exclusion Criteria

Use of other nasal decongestant; use of analgesics and corticosteroids not described in the protocol; hypersensitivity (allergy) to components of the formula; use of topical medication in the nasal region; pregnant and lactating women; drinking alcohol during treatment; another surgery associated;
Use of Gelfoan; packing and splints;
Patients who have had surgery under general anesthesia; other medical conditions considered by the investigator as reasonable for the disqualification of the individual participate in the study; postoperative complications (septal hematoma, heavy bleeding or tamponade requiring return to the operating room or infection).

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath